Cerebrospinal fluid liquid biopsies for medulloblastoma
- PMID: 34912051
- DOI: 10.1038/s41571-021-00590-1
Cerebrospinal fluid liquid biopsies for medulloblastoma
Comment on
-
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies.Cancer Cell. 2021 Nov 8;39(11):1519-1530.e4. doi: 10.1016/j.ccell.2021.09.012. Epub 2021 Oct 21. Cancer Cell. 2021. PMID: 34678152 Free PMC article.
References
-
- Hovestadt, V. et al. Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat. Rev. Cancer 20, 42–56 (2020). - DOI
-
- Diaz, L. A. Jr & Bardelli, A. Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol. 32, 579–586 (2014). - DOI
-
- De Mattos-Arruda, L. et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat. Commun. 6, 8839 (2015). - DOI
-
- Martínez-Ricarte, F. et al. Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid. Clin. Cancer Res. 24, 2812–2819 (2018). - DOI
-
- Escudero, L. et al. Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma. Nat. Commun. 11, 5376 (2020). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical